Back
AN2 Therapeutics Stock Price Chart
Sponsored
ANTX
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
44
ANTX
AN2 Therapeutics
Last Price:
$1.38
Seasonality Move:
-47.68%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
AN2 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.36 | Buy |
20-day SMA: | 1.43 | Sell |
50-day SMA: | 1.22 | Buy |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 1.36 | Buy |
20-day EMA: | 1.36 | Buy |
50-day EMA: | 1.3 | Buy |
200-day EMA: | 3.13 | Sell |
AN2 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 54.44 | Buy |
Chaikin Money Flow: | 331569 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.23 - 1.53) | Buy |
Bollinger Bands (100): | (0.88 - 1.56) | Buy |
AN2 Therapeutics Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for AN2 Therapeutics Stock
Is AN2 Therapeutics Stock a Buy?
-
AN2 Therapeutics share price is 1.40 while ANTX 8-day simple moving average is 1.36, which is a Buy signal.
-
The stock price of ANTX is 1.40 while AN2 Therapeutics 20-day SMA is 1.43, which makes it a Sell.
-
AN2 Therapeutics 50-day simple moving average is 1.22 while ANTX share price is 1.40, making it a Buy technically.
-
ANTX stock price is 1.40 and AN2 Therapeutics 200-day simple moving average is 1.88, creating a Sell signal.
ANTX Technical Analysis vs Fundamental Analysis
Sell
44
AN2 Therapeutics (ANTX)
is a Sell
Is AN2 Therapeutics a Buy or a Sell?
-
AN2 Therapeutics stock is rated a SellThe current AN2 Therapeutics [ANTX] share price is $1.40. The Score for ANTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
AN2 Therapeutics Stock Info
Market Cap:
41.8M
Price in USD:
1.40
Share Volume:
512.4K
AN2 Therapeutics 52-Week Range
52-Week High:
22.22
52-Week Low:
0.87
Sell
44
AN2 Therapeutics (ANTX)
is a Sell
AN2 Therapeutics Share Price Forecast
-
What is the AN2 Therapeutics stock price today?The AN2 Therapeutics stock price is 1.40 USD today.
-
Will ANTX stock go up or go down?AN2 Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is AN2 Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, AN2 Therapeutics is overvalued.
Is AN2 Therapeutics Stock a Buy?
-
AN2 Therapeutics share price is 1.40 while ANTX 8-day exponential moving average is 1.36, which is a Buy signal.
-
The stock price of ANTX is 1.40 while AN2 Therapeutics 20-day EMA is 1.36, which makes it a Buy.
-
AN2 Therapeutics 50-day exponential moving average is 1.30 while ANTX share price is 1.40, making it a Buy technically.
-
ANTX stock price is 1.40 and AN2 Therapeutics 200-day simple moving average is 3.13, creating a Sell signal.
Fundamental Analysis of AN2 Therapeutics
Is AN2 Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $0.29 per share.
Technical Analysis of AN2 Therapeutics
Should I short AN2 Therapeutics stock?
-
ANTX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting AN2 Therapeutics is a Buy
-
AN2 Therapeutics Relative Strength Index (RSI) is 54.44, which suggest AN2 Therapeutics is overbought
-
The Bollinger Bands (25) for AN2 Therapeutics is (1.23 - 1.53), which suggest AN2 Therapeutics is a Buy
-
The Bollinger Bands (100) for AN2 Therapeutics is (0.88 - 1.56), which suggest AN2 Therapeutics is a Buy
* AN2 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.